Use of Teplizumab to Modulate Stage 2 Type 1 Diabetes in Two Individuals With Autoimmune Polyendocrine Syndrome 1

What is it about?

This case report details the treatment of two teens with APS-1 and stage 2 type 1 diabetes. The application of immune therapy with teplizumab to APS-1 has not bee previously described. Information about treatment, and clinical responses are provided. Information about immune responses ad pancreatic imaging are provided for one individual.

Featured Image